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The objective of this study was to evaluate, spectrophotometrically, the compatibility of  non-mucinated 
polyethylene glycol (PEG) 4000 and non-PEGylated mucin in a PEGylated mucin matrices for drug 
delivery application. Mucin was extracted from the giant African land snails (Archachatina maginata) 
using chilled acetone and characterized in terms of qualitative properties and solubility profile. 
Polymeric matrices composed of PEG 4000 and mucin in ratios of 2:0 (A), 1:1 (B), 2:1(C) and 3:1 (D) 
were prepared by co-precipitation using chilled acetone. The matrices were characterized with respect 
to compatibility using the Fourier transform infrared (FT-IR) spectroscopy. Results of the qualitative 
tests performed on the snail mucin showed that carbohydrates, proteins and trace amounts of fats were 
present; the extracted mucin was light-brownish in colour, with a pleasant meaty odour. Snail mucin, 
when dispersed in water yielded a slightly viscous dispersion, but is not soluble in ethanol, acetone, 0.1 
M sodium hydroxide, ammonium hydroxide and sulphuric acid. The presence of different peaks in the 
FT-IR spectra of the PEGylated mucin matrices compared with the non-PEGylated mucin (2:0) matrix 
and non-mucinated PEG 4000 (0:2) matrix indicated the formation of  new polymers, which could be 
employed in drug delivery. This study has shown that PEGylation of mucin gives rise to new polymeric 
system with principal FT-IR peaks quite different from those of non-PEGylated mucin and non-
mucinated PEG, and this may be employed in the delivery of drugs. 
 




INTRODUCTION          
 
Drug delivery can be of importance for both new chemical 
entities as well as established drugs. The basic goal of 
any drug delivery system is to achieve steady state of 
blood concentration or tissue level that is therapeutically 
effective and non-toxic for an extended period of time 









gically active molecules are limited in their therapeutic 
values by properties such as poor solubility, limited 
bioavailability, and rapid elimination (Muller et al., 2000). 
In addition, while the beneficial effects of many drugs 
arise from their interaction with specific tissues, their 
exposure to other cell types frequently leads to undesira-
ble side effects and toxicity (Gillies and Frechet, 2004). In 
recent decades, there has been increased awareness of 
the need to develop drug delivery systems to improve the 
properties of therapeutic compounds, increase their 
effectiveness, and reduce their harmful side effects. Oral 
administration of therapeutic agents represents by far the 
easiest, safest and most convenient route of drug deli-
very, especially in the case of chronic therapies (Kreuter, 
1991). Unfortunately, the oral delivery route is beset with 
problems such as gastrointestinal (GI) destruction of 
labile molecules and low levels of macromolecular 
absorption (Francis et al., 2004). The development of oral 
forms of many drugs however remains a challenge either 
on account of their stability or their absorption from the 
GIT thus leading to sub-therapeutic bioavailability (Kreuter, 
1991). To reduce the impact of digestive enzymes and 
ensure the absorption of bioactive agents in an unaltered 
form, molecules may be incorporated into polymeric 
matrices, which could shield the encapsulated drug from 
the external harsh conditions, and may favour uptake by 
intestinal cells (Delie and Blanco-Prieto, 2005). Many 
polymers have been used in the formulation of polymeric 
matrices (Ravi-Kumar, 2000; Pamujula et al., 2004; Lagarce 
et al., 2005; Bernkop-Schnurch et al., 2004; Attama and 
Nwabunze, 2007). The engineering of new polymer bio-
materials with special physicochemical properties appears 
to be an answer to the afore-mentioned problems. To 
obtain new polymer biomaterials with better physicoche-
mical qualities that will meet the carrier needs of challen-
ging drug molecules, blending of polymers with desirable 
properties becomes imperative. Thus, mucin and PEG 
could be blended to improve the physico-chemical pro-
perties of the individual polymers. 
Mucins are high molecular weight (0.2 – 10 million 
Dalton)  glycoproteins containing both highly glycosylated 
domains and naked domains. The glycosylated domains 
are enriched in serine and threonine residues which serve 
as anchoring points for oligosaccharide chains. These O-
linked oligosaccharide side chains are complex both in 
terms of composition and length. The naked domains are 
typically found in the N-terminal and C- terminal parts of 
the protein and are enriched in cysteine residues (Carlstedt 
et al., 1983). The cysteine residues can form intermole-





as oligomers composed of several end-to-end linked 
mucin subunits (Perez and Proust, 1987). A common 
feature of mucins, apart from a high molecular weight and 
a high carbohydrate content (68 - 81%), is the abundance 
of negatively charged groups. The negative charges arise 
mainly from sialic acid residues and in some cases from 
sulphated sugars. These acidic groups account for the 
low isoelectric point (2-3) of mucins (Durrer et al., 1995). 
The basic amino acids of the protein component are 
serine and threonine. The glycosylated regions of mucins 
interact favourably with water and force the molecule to 
an extended random coil conformation, and the high 
molecular weight enables individual mucin molecules to 
overlap and entangle at relatively low concentrations (Lee 
et al., 2005). These features are ideal with respect to the 
formation of hydrogels. Studies have shown that recon-
stucted mucous gels from mucins have similar rheolo-
gical properties as native mucous gels at physiological 
concentrations (Raynal et al., 2003). The ability of mucin 
to form the structural backbone of the mucous gel is one 
of its most important functions (Raynal et al., 2003). 
There is an on-going effort aimed at improving the 
potential use of mucin in controlled delivery of certain 
drugs. One of the strategies that have been successfully 
employed is PEGylation (Momoh et al., 2010; Momoh et 
al., 2011; Momoh et al., 2010). Previous studies on 
PEGylation (the process of attaching PEG to any 
polymer, or the molecular attachment to polyethylene gly-
cols with different molecular weights to active drug mole-
cules or surface treatment of drug-bearing particles with 
PEGs) have shown that the interaction between PEG and 
mucin is either molecular interaction in a solvent which 
resulted in the formation of new bond or attachment of 
the PEG to a functional group in the protein molecule to 
form a copolymer (Schnurrer and Lehr, 1996). This tech-
nology is one of the most promising and extensively 
studied strategies for improving the pharmacokinetics of 
drugs (Abuchowski et al., 1977). Clinically proven 
PEGylation technology can improve the performance and 
dosing convenience of peptides, proteins, some water 
soluble drugs, antibodies, oligonucleotides and many small 
molecules by optimizing pharmacokinetics, increasing 
bioavailability and decreasing immunogenicity and dosing 
frequency. PEGylation has been shown to increase the-
rapeutic efficacy by enabling increased drug concen-
tration, improved biodistribution, and longer dwelling time 
at the site of action (Kodera et al., 1998). This would 
result in the achievement of therapeutic drug concentra-
tions with less frequent dosing which would be a signi-
ficant benefit to patients who are taking injected drugs
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and long time medication for example in diabetes mana-
gement. Therefore, among the different polymer-based 
drug delivery systems, PEGylated polymeric bioadhesive 
microparticles represent a promising delivery vehicle 
especially intended for short-acting active pharmaceutical 
ingredients (APIs) employed in chronic therapies in order 
to improve their therapeutic effects.  
Recently, PEGyalted mucin matrices were characte-
rized with respect to thermal properties. The results of the 
thermal properties of PEGylated mucin which was mea-
sured by differential scanning calorimetry (DSC) indicated 
that an interaction occurred between PEG and mucin 
(Momoh et al., 2010). This serves as a basis for further 
characterization of the interaction between PEG and 
mucin in PEGylated mucin matrices for drug delivery 
application. Fourier transform infrared (FT-IR) spectro-
scopic analysis can be used to determine the functional 
groups of the molecules (Sahoo et al., 2012; Sahoo et al., 
2012; Sahoo et al., 2011). Therefore, to obtain more 
information in detail about chemical interaction between 
PEG and mucin, the FT-IR analysis was carried out. In 
this study, admixtures of PEG 4000 and mucin obtained 
from African land snail (Archachatina marginata) were 
prepared by combining the two at different ratios. Some 
physicochemical properties as well as compatibility of the 
PEGylated mucin matrices were assessed. The objective 
of this study was to evaluate, spectroscopically, the com-
patibility of non-mucinated polyethylene glycol (PEG) 
4000 and non-PEGylated mucin in a PEGylated mucin 
matrices for drug delivery application.   
 
 
MATERIALS AND METHODS 
 
The following materials were purchased from their local suppliers 
and used without further purification: polyethylene glycol-4000 (Ph. 
Eur. Carl Roth GmbH + Co.KG Karlsruhhe Germany), citric acid, 
sodium hydroxide (Merck, Germany), methyl red, ethanol, nitric 
acid, silver nitrate, tetraoxosulphate (vi) acid, sodium chloride, 
acetone, concentrated hydrochloric acid (BDH, England). The giant 
African land snails (A. marginata) used were procured from a local 
market in Nsukka, Enugu State. All other reagents were of 
analytical grade and were used as such. 
 
 
Extraction of snail mucin (slime) 
 
The method of Adikwu and Nnamani (2005) was employed for the 
extraction with modifications. The giant African land snails (A. 
maginata) were washed with clean water and the shells were 
knocked open at the apex and a spirally coiled rod was inserted to 
remove the fleshy body. The mucus layer (slime mucus) was gently 
scraped off from the fleshy parts, pooled together in a container and 
precipitated with chilled acetone. These precipitates were then dried 
with a flush of cold air (-4°C) to obtain greyish-brown flakes of the 
snail mucin, which were powdered and used for the study. 
 
 
Physicochemical properties of snail mucin 
 
Some physicochemical properties of the snail mucin were also 
assessed using standard procedures (Adikwu and Ikejiuba, 2005). 








Two drops of water and 1 ml of dilute sodium hydroxide were added 
to 2 % dispersion of mucin in water. Two drops of 1 % copper sul-
phate solution were added with the solution shaken thoroughly after 
each drop and observed. A purple or pink colour shows the pre-




Two drops of concentrated nitric acid were carefully added to 2% 
dispersion of mucin in water. A white precipitate was formed, which 
turned yellow on heating. The contents of the test tube were cooled, 
three drops of dilute sodium hydroxide solution added and the 
precipitate observed. A yellow colour which changes to orange 
indicates the presence of proteins. 
 
 
Test for fats and oils 
 
A drop of the acetone extract of the mucin was placed on a filter 
paper. The solvent was allowed to evaporate and the filter paper 
observed carefully for any transluscence. 
 
 
Test for sugars 
 
Three drops of freshly prepared Fehling’s solutions I and II were 
added to 1% w/v aqueous dispersion of snail mucin which was then 
heated in a boiling water bath for 5 min and observed. 
 
 




Two drops of 1% iodine solution were added to 1 ml of 1% w/v of 




Two drops of ᾳ-naphthol solution was added to 2 ml of the snail 
mucin dispersion and the two mixed thoroughly. Then 1 ml of 
concentrated sulphuric acid was gently poured down the side of the 
tube and observed. 
 
Tollen’s reagent test 
 
Tollen’s reagent prepared as 1 ml of 5% silver nitrate solution was 
treated with a few drops of  5 % sodium hydroxide solution. A 
volume of aqueous ammonia just enough to redissolve the precipi-
tate was added to 3 drops of the snail mucin dispersion and the 
mixture warmed in a boiling water bath for few minutes. The colour 
of the precipitate formed was observed. 
 
Solubility profile of snail mucin 
 
The solubility of snail mucin in several solvents was determined by 
dispersing 100 mg of the snail mucin in definite volumes of each 
solvent- acetone, ethanol, water, sodium hydroxide, hydrochloric 
acid and ammonium hydroxide respectively at different tempera-
tures (25, 30, 40°C). 
 




Table 1. Physicochemical properties of snail mucin. 
 
Test Observation Inference 
Carbohydrate +++ Present 
Protein ++ Present 
Fats + Present 
 




Table 2. Solubility profile of snail mucin. 
 
Temperature (°C) Acetone Ethanol 0.1 M NaOH 0.1 M H2SO4 0.1 M NH4OH H2O 
25 - - - - - - 
30 - - - - - + 
40 - - - - - ++ 
 




Preparation of PEGylated-mucin matrices 
 
Polymer hybrids (matrices) were generated from mucin and 
poly(ethylene glycol) (PEG Mw 4000) by controlled coacervation in 
aqueous medium (Momoh et al., 2010; Momoh et al., 2011; Momoh 
et al., 2010). The matrices were prepared in the following molecular 
ratios (M:P): 1:1, 2:1, 3:1, 2:0, 0:2. Briefly, known quantities of 
mucin and PEG 4000 were weighed into separate 100 ml beakers 
and 20 ml of distilled water was added into the samples and 
allowed to stand for 72 h for interaction of the solvent and the 
polymers. The contents of the two beakers were then mixed and 
allowed to stand for another 72 h for molecular interaction. The 
hybrids were precipitated with chilled acetone, dried, pulverized and 
kept in an airtight container until used. 
 
 
Spectroscopic characterization of the matrices 
 
FTIR spectroscopy study was conducted using a Shimadzu FTIR 
8300 Spectrophotometer (Shimadzu, Tokyo, Japan) and the 
spectrum was recorded in the wavelength region of 4000 to 400 cm
-
`1





range. The procedure consisted of dispersing a 5 mg sample in KBr 
and compressing into discs by applying a pressure of 5 tons for 5 
min in a hydraulic press. The pellet was placed in the light path and 




RESULTS AND DISCUSSION 
 
Physicochemical properties of snail mucin 
 
Results of the physicochemical tests performed on the 
snail mucin (Table 1) showed that carbohydrates, 
proteins and trace amounts of fats were present. This is 
consistent with previous reports (Carlstedt et al., 1983; 
Perez and Proust, 1987; Durrrer et al., 1995; Lee et al., 
2005; Raynal et al., 2003). In both wet and dry states, the 
extracted mucin was light-brownish in colour, with a 
pleasant meaty odour. Snail mucin when dispersed in 
water yielded a slightly viscous dispersion (Table 2). The 
snail mucin is not soluble in ethanol, acetone, 0.1 M 
sodium hydroxide, ammonium hydroxide and sulphuric 
acid (Table 2), in agreement with previous reported stu-
dies ((Momoh et al., 2010, 2010, 2011; Adikwu and 
Nnamani, 2005; Adikwu and Ikejiuba, 2005).  
 
 
Fourier transform infrared (FT-IR) spectroscopy 
 
The IR spectrum of a given compound is always unique 
and characteristic. Thus, IR spectroscopy is a quick and 
relatively cheap technique for identifying compounds 
(Sahoo et al., 2012; Sahoo et al., 2012; Sahoo et al., 
2011; Builders et al., 2008). FT-IR spectra of the matrices 
(2:0, 0:2, 1:1, 2:1 and 3:1) are shown in Figures 1 – 5 . 
FT-IR spectra of non-PEGylated mucin (2:0) matrix, non-
mucinated PEG (0:2) matrix and PEGylated mucin (1:1, 
2:1 and 3:1) matrices were carried out as finger prints to 
identify PEGylated mucin relative to non-PEGylated mucin 
and non-mucinated PEG matrices. FT-IR spectrum of 
non-PEGylated mucin matrix (that is, mucin alone 2:0) 
(Figure 1) shows that principal peaks were observed at 
wave numbers of 1074.39, 1240.27, 1528.64, 1641.48, 
2946.36, 3275.24 and 3421.83 cm
-1
 corresponding to C-
N vibrations, -C-O stretching, N-H bending vibration for 
secondary amines, C=C stretching of α,β–unsaturated 
ring, C-H stretching, O-H stretching and N-H amide ben-
ding, respectively. 
FT-IR spectrum of non-mucinated PEG matrix (that is, 
PEG 4000 alone 0:2) (Figure 2) shows characteristic peaks 
at 840.99, 950.94, 1114.89, 1273.06, 1355.04, 1466.91, 
2882.71 and 3429.55 cm
-1
 corresponding to aromatic C-H 
bending (2 adjacent free H’s), aromatic C-H bending (1 
FT-IR spectra of PEGylated mucin matrices (that is, 1:1, 
2:1 and 3:1) (Figures 3 - 5) were different from those of 
non-PEGylated mucin matrix (2:0) and non-mucinated 
PEG matrix (0:2). Spectrum of 1:1 matrix (Figure 3)
 










shows strong peaks at 838.10, 956.72, 1116.82, 1264.38, 
1362.75, 1536.35, 1665.59, 2885.60 and 3298.38 cm
-1
 
corresponding to aromatic C-H deformation (2 adjacent 
free H’s), C-N vibrations, C-O stretching (strong), C-O 
stretching, C-H deformation (CH3), N-H bending vibration 
for secondary amines, C=C stretching of α,β–unsaturated 
ring, O=C-H stretching and N-H amide bending, res-
pectively; in 2:1 matrix, the characteristic peaks were 
found at 625.92, 1113.93, 1251.84, 1404.22, 1679.09, 
2888.50 and 3444.02 cm (Figure 4) due to aromatic C-H 
deformation, C-O stretching, C-O stretching, C-H defor-
mation (CH3), C=C stretching of α,β–unsaturated ring, C-
H stretching and N-H amide bending, respectively; while 
the FT-IR spectrum of 3:1 matrix (Figure 5) shows that 
principal peaks were observed at wave numbers of 
595.06, 1079.21, 1244.13, 1450.52, 1597.11, 2889.46
 






Figure 2. FT-IR spectrum of polymer matrix (0:2) (PEG-4000). 
 






Figure 3.  FT-IR spectrum of polymer matrix (1:1). 
 












 corresponding to aromatic C-H defor-
mation, C-N vibrations, C-O stretching, C=H deformation 
(CH3, CH2), aromatic C=C (conjugated ring), C-H stret-
ching and N-H amide bending, respectively. FT-IR spec-
tra of 2:1 and 3:1 matrices (Figures 4 and 5) showed 
decrease in the number of peaks due to overlapping of 
peaks corresponding to 2:0 (mucin) and 0:2 (PEG 4000) 
matrices. The characteristic differences between the 
spectra of PEGylated mucin matrices (1:1, 2:1 and 3:1) 
on one hand and between the spectra of PEGylated 
 










mucin matrices and those of non-PEGylated mucin (2:0) 
and non-mucinated PEG (0:2) matrices on the other hand 
further indicate that new polymeric materials were formed, 
consistent with a similar report on interaction studies of 
mucinated cellulose based on FT-IR by Builders et al. 
(2008). 
Although PEGyalted mucin matrices (prepared with PEG 
2000 and snail mucin) (Momoh et al., 2010; Momoh et al., 
 




2011; Momoh et al., 2010) had been characterized with 
respect to thermal properties by differential scanning 
calorimetry (DSC)
 
(Momoh et al., 2010), this serves as a 
basis for further characterization of the interaction bet-
ween PEG and mucin in PEGylated mucin matrices for 
drug delivery application. FT-IR spectroscopic analysis 
can be used to determine the functional groups of the 
molecules (Sahoo et al., 2012; Sahoo et al., 2012; Sahoo 
et al., 2011). Therefore, to obtain more information in de-
tail about chemical interaction between PEG and mucin, 
the FT-IR analysis was carried out on PEGylated mucin 
matrices prepared with PEG 4000 and snail mucin. The 
presence of different peaks in the FT-IR spectra of the 
PEGylated mucin matrices compared with the non-
PEGylated mucin (2:0) matrix and non-mucinated PEG 
4000 (0:2) matrix indicated the formation of  new poly-
mers, which could be employed in drug delivery. Results 
obtained in this study is in agreement with earlier reports 
on the drug delivery potential of PEGylated mucin 
(Momoh et al., 2010). The novelty embodied in this 
research is that this is the first spectroscopic study to be  






The engineering of new polymer biomaterials could be 
employed to address some problems associated with 
delivery of some APIs and biomolecules. To obtain new 
polymer biomaterials that will meet the carrier needs of 
challenging drug molecules, blending of polymers with 
desirable properties becomes imperative. In this study, 
admixtures of PEG 4000 and mucin obtained from 
African land snail (A. marginata) were prepared by com-
bining the two at different ratios. Preliminary spectro-
scopic characterization was performed on the PEGylated 
mucin matrices using  fourier transform infra-red spectro-
scopic characterization. Results obtained indicated that a 
new polymeric carrier was made from admixtures of 
mucin and PEG 4000 by PEGylation technology. Further 
solid state spectroscopic charcterization (WAXD and 
SAXD) studies on PEGylated mucin are currently on-
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